Finding older adults who can safely benefit from lung cancer screening
Official title: Identifying older adults who benefit from lung cancer screening
Funded at Northern California Institute/res/edu · NIH-10910151 · Data updated 2026-11-12
This study is looking at how to help older adults aged 50-80 decide if lung cancer screening is right for them by figuring out who is healthy enough to benefit from it without facing unnecessary risks.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 1, 2023 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $153,300 |
| NIH project number | 5R03AG082924-02 |
| Project ID | NIH-10910151 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults aged 50-80 who are considering lung cancer screening and have no advanced comorbidities.
✕Less likely to help
Patients with advanced comorbidities or those outside the age range of 50-80 may not benefit from this research.
What this research studies
This research investigates how to identify older adults, specifically those aged 50-80, who are healthy enough to benefit from lung cancer screening while minimizing potential harms. The study aims to create individualized assessments of the net benefits of screening based on each person's health status. By analyzing national data, the research will explore the relationship between health conditions and the outcomes of lung cancer screening, focusing on preventing unnecessary complications. The goal is to improve decision-making regarding lung cancer screening for older adults.
Why it matters
Potential benefit: If successful, this research could help ensure that older adults receive lung cancer screenings that are beneficial and safe for their specific health conditions.
How similar studies have gone: Other research has shown success in using individualized health assessments to improve screening outcomes, making this approach promising.
Where this research is happening
-
Northern California Institute/res/edu
San Francisco, United States Active
Researchers
- Principal investigator: Rustagi, Alison Silvis — Northern California Institute/res/edu
- Study coordinator: Rustagi, Alison Silvis
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.